Quantcast

Indy Standard

Monday, December 23, 2024

Congressional Record publishes “INTRODUCTION OF THE RESOLUTION EXPRESSING SUPPORT FOR THE DESIGNATION OF THE MONTH OF NOVEMBER 2021 A.....” in the Extensions of Remarks section on Nov. 12, 2021

Politics 1 edited

André Carson was mentioned in INTRODUCTION OF THE RESOLUTION EXPRESSING SUPPORT FOR THE DESIGNATION OF THE MONTH OF NOVEMBER 2021 A..... on page E1228 covering the 1st Session of the 117th Congress published on Nov. 12, 2021 in the Congressional Record.

The publication is reproduced in full below:

INTRODUCTION OF THE RESOLUTION EXPRESSING SUPPORT FOR THE DESIGNATION

OF THE MONTH OF NOVEMBER 2021 AS ``PANCREATIC CANCER AWARENESS MONTH''

______

HON. ANDRE CARSON

of indiana

in the house of representatives

Friday, November 12, 2021

Mr. CARSON. Madam Speaker, I am pleased to introduce a bipartisan resolution today with my colleagues, Representatives Eshoo, McKinley, and McClain. Our resolution raises awareness about pancreatic cancer and the importance of increased Congressional funding for research by expressing support for the designation of the month of November 2021 as Pancreatic Cancer Awareness Month. I am grateful for Representatives Eshoo, McKinley, and McClain's leadership in helping to combat pancreatic cancer.

Recently, pancreatic cancer has killed three American icons: Congressman John Lewis, Congressman Alcee Hastings, and Supreme Court Justice Ruth Bader Ginsburg. Accurately described as a silent killer, this disease does not have an early detection test, so unfortunately, by year's end, pancreatic cancer will have killed an estimated 47,050 Americans and is the third largest cause of cancer-related death in our country. As COVID-19 continues to rob us of our fellow Americans, pancreatic cancer continues to devastate thousands of American families and communities. In my home state of Indiana, nearly 1,000 Hoosiers will be killed by pancreatic cancer by year's end, and almost 2,000 Hoosiers will be newly diagnosed with this terrible disease. Nationwide, an additional 60,430 Americans will be diagnosed with pancreatic cancer this year.

These horrific statistics highlight how few tools exist to detect this disease and, as a result, the immense pain and suffering it causes. Alarmingly, pancreatic cancer still has no early detection test to quickly and accurately determine the presence of this cancer. As a result, it is very difficult to detect this cancer before it has advanced to later--and more deadly--stages. Tragically, 72 percent of pancreatic cancer patients live less than one year following their diagnosis. This was the case for our colleague, Congressman John Lewis, who was killed by pancreatic cancer less than a year following his diagnosis.

The COVID-19 pandemic has also highlighted how longstanding health disparities and lack of access to care results in disproportionate numbers of infections and deaths from this virus in communities of color. Sadly, the same is true with pancreatic cancer. The incidence rate for pancreatic cancer among Black Americans is twenty percent higher than that of any other racial demographic and the death rate is seventeen percent higher for Black men than for white men. In this way, the lack of pancreatic cancer early detection research accelerates the racial inequities in our health care system, with devastating consequences for minorities.

To help detect pancreatic cancer earlier and to help address racial inequities, the 117th Congress has a unique opportunity to make historic investments in pancreatic cancer research at the Department of Defense (DoD). Congress can do this by increasing funding to pancreatic cancer research. Within this research funding, DoD should include early detection research as a major funding priority to help more patients detect this deadly disease early. In fact, if diagnosed early, the 5-

year survival rate for pancreatic cancer patients is above 80 percent. Current pancreatic cancer research funding remains at a fraction of the level that our fellow Americans struggling with this disease deserve. That's why it is so critical that we raise awareness about how deadly and destructive this cancer is to our American family, and why increasing pancreatic cancer research is critical to lowering this disease's deadliness.

Moreover, at a time when our country is having a national conversation about the deep disparities in access to health care for Black and Brown people during the COVID-19 pandemic, Congress must do everything within our power to improve health outcomes through research and treatment, and that includes pancreatic cancer. And in order to ensure that we improve outcomes, we need to raise awareness with the American public and our colleagues in Congress about just how deadly this cancer is and why we need to find early detection tools, effective treatments and reduce this disease's disproportionate impact on communities of color.

I urge my colleagues in the House to support this resolution.

____________________

SOURCE: Congressional Record Vol. 167, No. 197

The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.

House Representatives' salaries are historically higher than the median US income.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS